Cargando…
Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients
Introduction: Randomized trials demonstrated ~95% efficacy of SARS-CoV-2 spike messenger RNA (mRNA) vaccines. Patients (pts) after allogeneic hematopoietic cell transplant (HCT) have a variable period of immune deficiency and the impact of diagnosis, treatment regimens, GvHD, and immunosuppression o...
Autores principales: | Baker, Melissa, Cortes, Maria, Ahn, Jaeil, Donato, Michele L., Kaur, Sukhdeep, Suh, Hyung C., Morawski, Alison, McKiernan, Phyllis, Einstein, Amy, Boonstra, Michele, Rowley, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701534/ http://dx.doi.org/10.1182/blood-2021-145642 |
Ejemplares similares
-
Following up children born preterm
por: Vijayalakshmi, P, et al.
Publicado: (2017) -
Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group
por: Bailén, Rebeca, et al.
Publicado: (2020) -
Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care
por: Colunga Pedraza, Perla R., et al.
Publicado: (2020) -
How We Did Bone Marrow Transplants amidst the COVID19 Pandemic
por: Kumar, Kishore, et al.
Publicado: (2020) -
Identification of Respiratory Viral Infection in Hematopoietic Stem Cell Transplant Recipients - Impact on Non Relapse Mortality
por: Imlay-Gillespie, Louise, et al.
Publicado: (2015)